dipyridamole has been researched along with cyclic gmp in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (17.74) | 18.7374 |
1990's | 21 (33.87) | 18.2507 |
2000's | 25 (40.32) | 29.6817 |
2010's | 5 (8.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balzarini, J; Borst, P; De Haas, M; Reid, G; Van Deemter, L; Wielinga, P; Wijnholds, J; Zelcer, N | 1 |
McElroy, FA; Philip, RB | 1 |
Asano, T; Hidaka, H; Ochiai, Y | 1 |
Bendtzen, K; Palit, J | 1 |
Best, LC; Holland, TK; Jones, PB; Martin, TJ; McGuire, MB; Preston, FE; Russell, RG; Segal, DS | 1 |
Kobayashi, A; Ogawa, K | 1 |
Hait, WN; Weiss, B | 1 |
Bai, L; Miyazaki, M; Namba, M; Wahid, S | 1 |
Gauthier, C; Le Bec, A; Lugnier, C; Soustre, H | 1 |
Robichon, A | 1 |
Angielski, S; Kuchta, G; Redlak, M; Szczepańska-Konkel, M | 1 |
Jahr, CE; Nawy, S | 1 |
Moreno, S; Tomes, C | 1 |
Akaishi, Y; Fukao, M; Kobayashi, T; Makita, MA; Makita, Y; Matsuno, K; Miyazaki, T; Sakuma, I; Yasuda, H | 1 |
Diocee, BK; Martin, W; Moodie, SA; Souness, JE | 1 |
Beavo, JA; Gillespie, PG | 1 |
Poltavchenko, GM; Sokolova, EN | 1 |
Ahlner, J; Andersson, RG; Axelsson, KL; Dahlström, U; Rydell, EL | 1 |
Bousseau-Lafortune, S; Coquil, JF; Franks, DJ; Hamet, P; Tremblay, J | 1 |
Abboud, HE; Dousa, TP | 1 |
Ahlner, J; Torfgård, KE | 1 |
Saeki, T; Saito, I | 1 |
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Mularoni, E; Piretto, V; Trovati, M | 1 |
Hartell, NA | 1 |
Amemiya, M; Asano, Y; Iimura, O; Ikeda, U; Kusano, E; Muto, S; Shimada, K | 1 |
Bode, DC; Buchholz, RA; De Garavilla, L; Dundore, R; Jackson, KN; Pagani, ED; Pratt, P; Silver, PJ; Volberg, ML | 1 |
Cheng, JB; Cohan, VL; Eskra, JD; Griffiths, RJ; Pazoles, CJ; Pettipher, ER; Showell, HJ; Turner, CR; Watson, JW | 1 |
Bell, A; Hipps, R; Meadow, W; Rudinsky, B | 1 |
Abman, SH; Clarke, WR; Ivy, DD; Kinsella, JP; Wiggins, JW; Ziegler, JW | 1 |
Dukarm, RC; Morin, FC; Russell, JA; Steinhorn, RH | 1 |
Fyhrquist, F; Saijonmaa, O | 1 |
Barba, G; Donald, A; MacAllister, RJ; Mullen, MJ | 1 |
Mullan, M; Paris, D; Town, T | 1 |
Aigrain, Y; de Lagausie, P; Dinh-Xuan, AT; Forgues, D; Mercier, JC; Thébaud, B | 1 |
Humphrey, J; Mullan, M; Paris, D; Parker, T; Town, T | 1 |
Blanco, E; De La Cruz, JP; Sánchez de la Cuesta, F | 1 |
Blaise, G; Costachescu, T; Derouin, M; Jiang, ZY | 1 |
Abraham, RZ; Kobzik, L; Moody, MR; Reid, MB; Stamler, JS | 1 |
Edvinsson, L; Jansen-Olesen, I; Khurana, TS; Kruuse, C; Olesen, J; Rybalkin, SD | 1 |
Baba, A; Enomoto, R; Lee, E; Matsuda, T; Mori, K; Takuma, K | 1 |
Enke, B; Forssmann, WG; Ghofrani, HA; Grimminger, F; Schermuly, RT; Seeger, W; Walmrath, D; Weissmann, N | 1 |
Naik, JS; Walker, BR | 1 |
Huang, Y; Kong, SK; Kwan, HY; Yao, X | 1 |
De Wolf, D; Foubert, L; Mareels, K; Mortier, E; Reyntjens, K; Van Belleghem, Y; Van Nooten, G | 1 |
Fujita, T; Goto, A; Onozato, ML; Tojo, A | 1 |
Aktas, B; Geiger, J; Hoenig-Liedl, P; Utz, A; Walter, U | 1 |
Baskakov, MB; D'yakova, EY; Kapilevich, LV; Kovalev, IV; Nosarev, AV | 1 |
De Somer, F; De Wolf, D; Foubert, L; Mortier, E; Reyntjens, K; Van Belleghem, Y; Van Nooten, G | 1 |
Azegami, Y; Kaneda, T; Nakajyo, S; Shimizu, K; Urakawa, N; Yamamoto, H | 1 |
Drake, MJ; Gillespie, JI | 1 |
Cogolludo, Al; Lodi, F; Losada, B; Lugnier, C; Moreno, L; Moro, M; Pérez-Vizcaíno, F; Tamargo, J; Villamor, E | 1 |
Barile, L; Giacomello, A; Lupi, F; Messina, E | 1 |
Abraham, R; Biaggioni, I; Diedrich, A; Farley, G; Gamboa, A; Paranjape, SY; Shibao, C | 1 |
Blumenthal, DK; Cheung, AK; Masaki, T; Zhuplatov, SB | 1 |
Jaworski, K; Kopcewicz, J; Szmidt-Jaworska, A | 1 |
Kim, HH; Liao, JK | 1 |
Alvarez, E; Cairrão, E; Morgado, M; Santos-Silva, AJ; Verde, I | 1 |
Døskeland, SO; Holmsen, H; Jensen, BO; Kleppe, R; Kopperud, R; Nygaard, G; Selheim, F | 1 |
Calabriso, N; Carluccio, MA; De Caterina, R; Martines, G; Massaro, M; Pellegrino, M; Scoditti, E; Storelli, C | 1 |
Chang, KH; Kim, YG; Lee, MY; Liu, Y; Oh, SJ | 1 |
Aronsen, L; Lysaa, R; Orvoll, E; Ravna, AW; Sager, G | 1 |
Botigelli, RC; Castro, FC; Del Collado, M; Fernandes, H; Leal, CLV; Schwarz, KL; Zaffalon, FG | 1 |
2 review(s) available for dipyridamole and cyclic gmp
Article | Year |
---|---|
Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: a mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates.
Topics: Adenosine; Adult; Cyclic AMP; Cyclic GMP; Dipyridamole; Drug Interactions; Humans; Male; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 1995 |
Translational therapeutics of dipyridamole.
Topics: Acute Coronary Syndrome; Animals; Cyclic AMP; Cyclic GMP; Dipyridamole; Disease Models, Animal; Endothelium, Vascular; Humans; Mice; Nitric Oxide; Oxidation-Reduction; Phosphodiesterase Inhibitors; Platelet Aggregation; Prognosis; Stroke; Survival Rate; Treatment Outcome | 2008 |
3 trial(s) available for dipyridamole and cyclic gmp
Article | Year |
---|---|
Effect of low dose of dipyridamole on glyceryl trinitrate tolerance in healthy volunteers.
Topics: Adult; Blood Pressure; Cyclic GMP; Dipyridamole; Double-Blind Method; Drug Tolerance; Female; Heart Rate; Humans; Male; Nitroglycerin | 1993 |
Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Topics: Adult; Alprostadil; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Delayed-Action Preparations; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Microfilament Proteins; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Reference Values; Serotonin; Signal Transduction; Vasodilator Agents | 2003 |
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole.
Topics: Acetylcholine; Adenosine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; Cardiovascular System; Cross-Over Studies; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Models, Biological; Nitric Oxide; Nitroprusside; Phosphoric Diester Hydrolases; Time Factors; Vasodilator Agents | 2005 |
57 other study(ies) available for dipyridamole and cyclic gmp
Article | Year |
---|---|
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5.
Topics: Acrylates; Biological Transport; Cell Division; Cells, Cultured; Humans; Multidrug Resistance-Associated Proteins; Nucleosides; Polymers | 2003 |
Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Blood Platelets; Cyclic GMP; Dipyridamole; Humans; Mopidamol; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Adhesiveness; Platelet Aggregation; Pyrimidines | 1975 |
Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Topics: Adenosine; Blood Platelets; Caffeine; Chromatography, DEAE-Cellulose; Cyclic AMP; Cyclic GMP; Depression, Chemical; Dipyridamole; Humans; In Vitro Techniques; Kinetics; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Platelet Aggregation; Theophylline | 1977 |
Modulation of human leucocyte migration inhibitory factor (LIF) by 3',5'-cyclic AMP, 3',5'-cyclic GMP and agents known to influence intracellular cyclic nucleotide metabolism.
Topics: Bucladesine; Cell Movement; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Dipyridamole; Humans; Isoproterenol; Leukocytes; Macrophage Migration-Inhibitory Factors; Norepinephrine; Nucleosides; Nucleotides, Cyclic; Papaverine; Phosphodiesterase Inhibitors | 1977 |
Mode of action of dipyridamole on human platelets.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Cell Membrane; Cyclic AMP; Cyclic GMP; Dipyridamole; Epinephrine; Epoprostenol; Humans; Malondialdehyde; Platelet Aggregation; Thromboxane B2; Time Factors | 1979 |
Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators.
Topics: Amyl Nitrite; Animals; Coronary Vessels; Cyclic AMP; Cyclic GMP; Diltiazem; Dipyridamole; Dogs; Heart Ventricles; Isosorbide Dinitrate; Myocardium; Nifedipine; Nitroglycerin; Papaverine; Radioimmunoassay; Vasodilator Agents | 1979 |
Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Calmodulin; Cyclic GMP; Dipyridamole; In Vitro Techniques; Kinetics; Leukemia; Leukemia L1210; Lymphocytes; Mice; Mice, Inbred DBA; Phosphodiesterase Inhibitors | 1979 |
Effects of intracellular cyclic AMP and cyclic GMP levels on DNA synthesis of young-adult rat hepatocytes in primary culture.
Topics: Age Factors; Animals; Cell Division; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dipyridamole; DNA; In Vitro Techniques; Liver; Male; Rats; Theophylline | 1992 |
Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Calcium Chloride; Calmodulin; Chromatography, Ion Exchange; Cyclic GMP; Cytosol; Dipyridamole; Heart Atria; Heart Ventricles; Kinetics; Myocardium; Papaverine; Purinones; Pyrrolidinones; Rana esculenta; Rana ridibunda; Rolipram; Substrate Specificity; Theophylline | 1992 |
A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Catalysis; Cattle; Chromatography, Affinity; Cyclic AMP; Cyclic GMP; Dipyridamole; Electrophoresis, Polyacrylamide Gel; Kinetics; Phosphorylation; Platelet Activation; Protein Kinases; Purinones; Substrate Specificity | 1991 |
The role of intrarenal adenosine in glomerular action of atrial natriuretic factor.
Topics: Adenosine; Adenosine Deaminase; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dipyridamole; Glucagon; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Saralasin; Sodium; Theophylline | 1991 |
cGMP-gated conductance in retinal bipolar cells is suppressed by the photoreceptor transmitter.
Topics: Alkaloids; Aminobutyrates; Animals; Cyclic GMP; Dark Adaptation; Dipyridamole; Electric Conductivity; Electrophysiology; Guanosine 5'-O-(3-Thiotriphosphate); Light; Neurotransmitter Agents; Phorbol Esters; Photoreceptor Cells; Retina; Staurosporine | 1991 |
cAMP analogs and selective inhibitors used to study low Km Mucor rouxii cAMP phosphodiesterase.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Centrifugation, Density Gradient; Cyclic AMP; Cyclic GMP; Dipyridamole; Hydrolysis; Mucor; Nicotinic Acids; Papaverine; Pyridazines; Theophylline | 1990 |
Dipyridamole potentiates the anti-aggregating effect of endothelium-derived relaxing factor.
Topics: Cyclic AMP; Cyclic GMP; Dipyridamole; Humans; In Vitro Techniques; Nitric Oxide; Platelet Aggregation Inhibitors | 1990 |
Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Aorta; Calcium; Cells, Cultured; Chromatography, Ion Exchange; Colforsin; Cyclic AMP; Cyclic GMP; Dipyridamole; Endothelium, Vascular; Isoquinolines; Kinetics; Purinones; Pyrazines; Pyrrolidinones; Rolipram; Swine; Tetrahydroisoquinolines | 1990 |
Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Binding Sites; Cattle; Cyclic GMP; Dipyridamole; Enzyme Activation; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Phosphodiesterase Inhibitors; Photoreceptor Cells; Purinones; Rats; Rod Cell Outer Segment; Trypsin | 1989 |
[Effect of adenosine on cyclic nucleotide levels in brain structures].
Topics: Adenosine; Animals; Brain; Cerebellum; Cerebral Cortex; Cyclic AMP; Cyclic GMP; Dipyridamole; Hippocampus; Hypothalamus; Male; Rats; Rats, Inbred Strains | 1988 |
Development of tolerance to glyceryl trinitrate in an isolated human peripheral vein and its relation to cyclic GMP metabolism.
Topics: Cyclic GMP; Dipyridamole; Drug Tolerance; Guanylate Cyclase; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin | 1986 |
Cyclic GMP binding and phosphodiesterase: implication for platelet function.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine Diphosphate; Blood Platelets; Carrier Proteins; Cyclic GMP; Dipyridamole; Humans; Intracellular Signaling Peptides and Proteins; Nitroprusside; Platelet Aggregation; Receptors, Cyclic AMP | 1984 |
Action of adenosine on cyclic 3',5'-nucleotides in glomeruli.
Topics: Adenosine; Animals; Cyclic AMP; Cyclic GMP; Dipyridamole; In Vitro Techniques; Kidney Cortex; Kidney Glomerulus; Kidney Medulla; Kinetics; Rats; Serotonin; Theophylline | 1983 |
Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta.
Topics: Animals; Aorta; Calmodulin; Chromatography, Affinity; Cyclic AMP; Cyclic GMP; Dipyridamole; Isoenzymes; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Swine; Vinca Alkaloids | 1993 |
Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cerebellum; Cyclic GMP; Dipyridamole; Long-Term Potentiation; Male; Phosphodiesterase Inhibitors; Purinones; Purkinje Cells; Rats; Rats, Wistar; Synaptic Transmission | 1996 |
Dipyridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells.
Topics: Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Dipyridamole; Interleukin-1; Male; Muscle, Smooth, Vascular; Nitric Oxide; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Analysis of Variance; Animals; Aorta, Abdominal; Blood Pressure; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Tolerance; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Purinones; Rats; Rats, Inbred SHR; Vasodilator Agents | 1996 |
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenalectomy; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dipyridamole; Epinephrine; Humans; Kinetics; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Monocytes; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piroxicam; Propranolol; Purinones; Pyrimidinones; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 1997 |
Effects of nebulized nitroprusside on pulmonary and systemic hemodynamics during pulmonary hypertension in piglets.
Topics: Administration, Inhalation; Aerosols; Animals; Blood Gas Analysis; Cyclic GMP; Dipyridamole; Hemodynamics; Hypertension, Pulmonary; Nitric Oxide; Nitroprusside; Oxygen Consumption; Pulmonary Circulation; Signal Transduction; Swine; Tolazoline; Vasodilation; Vasodilator Agents | 1998 |
Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Topics: Administration, Inhalation; Adolescent; Adult; Aorta; Blood Pressure; Bronchodilator Agents; Cardiac Catheterization; Cardiac Output; Child; Child, Preschool; Cyclic GMP; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Hypoxia; Infant; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Circulation; Vascular Resistance; Vasodilator Agents | 1998 |
Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension.
Topics: Animals; Animals, Newborn; Cyclic GMP; Dipyridamole; Disease Models, Animal; Female; Hemodynamics; Humans; In Vitro Techniques; Infant, Newborn; Mesenteric Arteries; Nitric Oxide; Persistent Fetal Circulation Syndrome; Phosphodiesterase Inhibitors; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Sheep | 1998 |
Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; Peptidyl-Dipeptidase A; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Purinones; Stimulation, Chemical; Thionucleotides; Umbilical Veins; Vasodilator Agents | 1998 |
Determinants of the response of human blood vessels to nitric oxide donors in vivo.
Topics: Adult; Bradykinin; Cyclic GMP; Dipyridamole; Forearm; Hand; Humans; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Radial Artery; Vascular Resistance; Vasodilation; Veins | 1999 |
Novel strategies for opposing murine microglial activation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cells, Cultured; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dipyridamole; Enzyme Inhibitors; Flavonoids; Guanylate Cyclase; Imidazoles; Indazoles; Isoenzymes; Lipopolysaccharides; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Microglia; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylcholine; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha | 2000 |
ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Cyclic GMP; Dipyridamole; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Hypertension, Pulmonary; Nitric Oxide; Nitroprusside; Peptides, Cyclic; Phosphodiesterase Inhibitors; Pregnancy; Pulmonary Circulation; Purinones; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Sheep; Vasoconstrictor Agents; Vasodilator Agents; Viper Venoms | 2000 |
beta-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents.
Topics: Amyloid beta-Peptides; Animals; Aorta; Cyclic GMP; Dipyridamole; Endothelin-1; In Vitro Techniques; Inflammation; Leukotriene B4; Microglia; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Rats; Vasoconstriction | 2000 |
Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
Topics: Adult; Aspirin; Blood Platelets; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Humans; Male; Neutrophils; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors | 2000 |
Treatment of pulmonary hypertension during surgery with nitric oxide and vasodilators.
Topics: Administration, Inhalation; Colectomy; Cyclic GMP; Dipyridamole; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Middle Aged; Nitric Oxide; Nitroglycerin; Vasodilator Agents | 2000 |
Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction.
Topics: Aminoquinolines; Animals; Cyclic GMP; Diaphragm; Dipyridamole; Enzyme Inhibitors; Guanylate Cyclase; Male; Muscle Contraction; Nitric Oxide; Nitroarginine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Second Messenger Systems | 1998 |
The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Basilar Artery; Cerebral Arteries; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Guinea Pigs; In Vitro Techniques; Isoenzymes; Male; Milrinone; Nitroprusside; Oxadiazoles; Pentoxifylline; Phosphodiesterase Inhibitors; Purinones; Quinoxalines; Vasodilation; Vasodilator Agents | 2001 |
Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model.
Topics: Alkaloids; Animals; Animals, Newborn; Apoptosis; Astrocytes; Carbazoles; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytochrome c Group; Dipyridamole; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Indoles; Mitochondria; Pentoxifylline; Peptide Hydrolases; Phosphodiesterase Inhibitors; Purinones; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Theophylline; Vinca Alkaloids | 2001 |
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dipyridamole; Disease Models, Animal; Drug Synergism; Guanylate Cyclase; Hypertension, Pulmonary; Infusions, Intravenous; Peptide Fragments; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Circulation; Rabbits | 2001 |
Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbon Monoxide; Cyclic GMP; Dipyridamole; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Oxadiazoles; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Circulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vascular Resistance; Vasodilation | 2001 |
cGMP abolishes agonist-induced [Ca(2+)](i) oscillations in human bladder epithelial cells.
Topics: Acetylcholine; Alkaloids; Bradykinin; Calcium Signaling; Calcium-Transporting ATPases; Carbazoles; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipyridamole; Drug Antagonism; Enzyme Inhibitors; Epithelial Cells; Humans; Indoles; Kinetics; Macrocyclic Compounds; Oxazoles; Phosphodiesterase Inhibitors; Urinary Bladder | 2001 |
Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Inhalation; Animals; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Drug Synergism; Hypertension, Pulmonary; Injections, Intravenous; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Recurrence; Substance Withdrawal Syndrome; Swine; Vascular Resistance | 2002 |
Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blotting, Western; Creatinine; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Immunohistochemistry; Isoquinolines; Kidney; Lipid Peroxides; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Phosphodiesterase Inhibitors; Phosphoproteins; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2003 |
Role of cyclic nucleotides in regulation of pulmonary artery tone in rabbits.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Cyclic GMP; Dipyridamole; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pulmonary Artery; Rabbits; Signal Transduction; Sympathomimetics; Theophylline; Vasodilator Agents | 2003 |
Intermittent nitric oxide combined with intravenous dipyridamole in a piglet model of acute pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthesia; Animals; Blood Pressure; Cardiac Output; Central Venous Pressure; Cyclic GMP; Dipyridamole; Hemodynamics; Hypertension, Pulmonary; Injections, Intravenous; Nitric Oxide; Pulmonary Artery; Swine; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Lack of cyclic nucleotide regulation of MBCQ-induced relaxation of rat ileal smooth muscle.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbachol; Cholinergic Agonists; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Ileum; Male; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Potassium; Purinones; Quinazolines; Rats; Rats, Wistar | 2003 |
The actions of sodium nitroprusside and the phosphodiesterase inhibitor dipyridamole on phasic activity in the isolated guinea-pig bladder.
Topics: Animals; Cyclic GMP; Dipyridamole; Female; Guinea Pigs; Muscle Contraction; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Pressure; Urinary Bladder | 2004 |
Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Animals, Newborn; Blotting, Western; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; In Vitro Techniques; Male; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Purinones; Sildenafil Citrate; Sulfones; Swine; Vasodilation; Vasodilator Agents | 2004 |
Cyclic nucleotides and neuroblastoma differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Neuroblastoma; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phthalazines; Purinones; Time Factors | 2004 |
Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation.
Topics: Aorta; Cell Cycle; Cell Proliferation; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipyridamole; Enzyme Inhibitors; Graft Occlusion, Vascular; Humans; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Saphenous Vein; Thionucleotides | 2006 |
Involvement of cyclic GMP in phytochrome-controlled flowering of Pharbitis nil.
Topics: 1-Methyl-3-isobutylxanthine; Cotyledon; Cyclic GMP; Dipyridamole; Flowers; Ipomoea nil; Light; Nitroprusside; Photoperiod; Phytochrome | 2008 |
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Colforsin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Female; Guanylate Cyclase; Histamine; Humans; In Vitro Techniques; Isoenzymes; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Naphthyridines; Nitroprusside; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Serotonin; Umbilical Arteries; Vasodilator Agents | 2008 |
Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Topics: Blood Platelets; Cell Adhesion Molecules; Cell Shape; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Drug Synergism; Humans; Microfilament Proteins; Models, Molecular; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation; Stroke; Thrombin | 2011 |
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes.
Topics: Anti-Inflammatory Agents; Cyclic AMP; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Down-Regulation; Humans; I-kappa B Proteins; Inflammation Mediators; Matrix Metalloproteinase 9; Monocytes; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Signal Transduction; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transcription Factor RelA; Tumor Necrosis Factor-alpha; U937 Cells | 2013 |
Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cyclic GMP; Dipyridamole; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Male; Nitric Oxide Synthase Type III; Phosphodiesterase Inhibitors; Phosphorylation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Thrombosis | 2013 |
Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
Topics: ATP-Binding Cassette Transporters; Caffeine; Carbolines; Cyclic AMP; Cyclic GMP; Dipyridamole; Humans; Imidazoles; Kinetics; Multidrug Resistance-Associated Proteins; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purinones; Sulfones; Tadalafil; Theophylline; Triazines; Vardenafil Dihydrochloride | 2014 |
Influence of nitric oxide and phosphodiesterases during in vitro maturation of bovine oocytes on meiotic resumption and embryo production.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blastocyst; Cattle; Cyclic AMP; Cyclic GMP; Dipyridamole; Female; Fertilization in Vitro; In Vitro Oocyte Maturation Techniques; Male; Meiosis; Nitric Oxide; Nitric Oxide Donors; Oocytes; Phosphodiesterase Inhibitors; Quinolones; S-Nitroso-N-Acetylpenicillamine; Sildenafil Citrate | 2017 |